DE60216296D1 - Biologische vorstufen für die perkutane verabreichung - Google Patents

Biologische vorstufen für die perkutane verabreichung

Info

Publication number
DE60216296D1
DE60216296D1 DE60216296T DE60216296T DE60216296D1 DE 60216296 D1 DE60216296 D1 DE 60216296D1 DE 60216296 T DE60216296 T DE 60216296T DE 60216296 T DE60216296 T DE 60216296T DE 60216296 D1 DE60216296 D1 DE 60216296D1
Authority
DE
Germany
Prior art keywords
sub
presentations
biological
percutaneous administration
represent independently
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60216296T
Other languages
English (en)
Other versions
DE60216296T2 (de
Inventor
Daniel Redoules
Pascal Bordat
Jean-Jacques Perie
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pierre Fabre Dermo Cosmetique SA
Universite Toulouse III Paul Sabatier
Original Assignee
Pierre Fabre Dermo Cosmetique SA
Universite Toulouse III Paul Sabatier
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pierre Fabre Dermo Cosmetique SA, Universite Toulouse III Paul Sabatier filed Critical Pierre Fabre Dermo Cosmetique SA
Application granted granted Critical
Publication of DE60216296D1 publication Critical patent/DE60216296D1/de
Publication of DE60216296T2 publication Critical patent/DE60216296T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C07D311/70—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with two hydrocarbon radicals attached in position 2 and elements other than carbon and hydrogen in position 6
    • C07D311/72—3,4-Dihydro derivatives having in position 2 at least one methyl radical and in position 6 one oxygen atom, e.g. tocopherols

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Nutrition Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Toxicology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Pyrane Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE60216296T 2001-09-17 2002-09-16 Biologische vorstufen für die perkutane verabreichung Expired - Lifetime DE60216296T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0111982A FR2829762B1 (fr) 2001-09-17 2001-09-17 Bioprecurseurs destines a une application percutanee
FR0111982 2001-09-17
PCT/FR2002/003148 WO2003024952A1 (fr) 2001-09-17 2002-09-16 Bioprecurseurs destines a une application percutanee

Publications (2)

Publication Number Publication Date
DE60216296D1 true DE60216296D1 (de) 2007-01-04
DE60216296T2 DE60216296T2 (de) 2007-06-21

Family

ID=8867346

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60216296T Expired - Lifetime DE60216296T2 (de) 2001-09-17 2002-09-16 Biologische vorstufen für die perkutane verabreichung

Country Status (11)

Country Link
US (1) US7084172B2 (de)
EP (1) EP1427717B1 (de)
JP (1) JP2005508908A (de)
AT (1) ATE346060T1 (de)
CA (1) CA2460783A1 (de)
CY (1) CY1106040T1 (de)
DE (1) DE60216296T2 (de)
ES (1) ES2275923T3 (de)
FR (1) FR2829762B1 (de)
PT (1) PT1427717E (de)
WO (1) WO2003024952A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT500404A1 (de) * 2003-07-17 2005-12-15 Jsw Res Forschungslabor Gmbh Chemische verbindungen enthaltend tocopherol sowie zumindest einen weiteren pharmazeutischen wirkstoff
EP3092220B1 (de) * 2013-09-25 2021-01-20 University of Florida Research Foundation, Inc. Vitamin-c-prodrugs und verwendungen davon
FR3020570B1 (fr) * 2014-04-30 2017-07-21 Pierre Fabre Dermo-Cosmetique Association d'un acide hyaluronique et d'un polysaccharide sulfate
KR102644587B1 (ko) * 2015-12-24 2024-03-07 (주)아모레퍼시픽 유사 세라마이드 화합물 및 그 제조방법

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2407726A (en) * 1941-08-07 1946-09-17 Univ Minnesota Methods of preparing chemical products
US2680749A (en) * 1951-12-01 1954-06-08 Eastman Kodak Co Water-soluble tocopherol derivatives
FR2608045B1 (fr) * 1986-12-12 1990-03-02 Chauvin Laboratoires Utilisation d'inhibiteurs de xanthine- oxydase, de piegeurs de radicaux libres oxygenes et de chelateurs du fer pour la fabrication d'une composition pharmaceutique destinee au traitement du glaucome et compositions pharmaceutiques destinees au traitement du glaucome
JPH03206021A (ja) * 1990-01-08 1991-09-09 Kanebo Ltd 養毛化粧料
CH681891A5 (de) * 1992-10-09 1993-06-15 Marigen Sa
JPH06287470A (ja) * 1993-04-05 1994-10-11 Mitsubishi Petrochem Co Ltd 耐摩耗性被覆組成物
FR2722094B1 (fr) * 1994-07-05 1997-07-11 Jcb Cosmetiques Composition orale pour reactiver le bronzage de lapeau a base d'un carotenoide et d'un tocopherol
CA2275867A1 (en) * 1996-11-12 1998-05-22 Tamarkin Pharmaceutical Innovation Ltd. Method for treatment of dermatological disorders
FR2791679B1 (fr) * 1999-03-31 2003-04-11 Fabre Pierre Dermo Cosmetique Bioprecurseurs aptes a liberer un derive retinoique par mise a profit de l'activite enzymatique de la surface cutanee et compositions pharmaceutiques et/ou cosmetiques
US6045826A (en) * 1999-04-02 2000-04-04 National Research Council Of Canada Water-soluble compositions of bioactive lipophilic compounds
KR100352986B1 (ko) * 2000-04-28 2002-09-18 주식회사 태평양 세라미드 유사 화합물 및 이의 제조방법, 및 이를함유하는 화장료 조성물
US7030265B2 (en) * 2001-01-11 2006-04-18 Chebigen, Inc. Retinol derivatives, the method of preparations and the uses thereof

Also Published As

Publication number Publication date
CA2460783A1 (fr) 2003-03-27
ATE346060T1 (de) 2006-12-15
US7084172B2 (en) 2006-08-01
CY1106040T1 (el) 2011-04-06
US20040236098A1 (en) 2004-11-25
FR2829762B1 (fr) 2004-02-13
FR2829762A1 (fr) 2003-03-21
ES2275923T3 (es) 2007-06-16
EP1427717B1 (de) 2006-11-22
DE60216296T2 (de) 2007-06-21
EP1427717A1 (de) 2004-06-16
PT1427717E (pt) 2007-02-28
JP2005508908A (ja) 2005-04-07
WO2003024952A1 (fr) 2003-03-27

Similar Documents

Publication Publication Date Title
CY1109989T1 (el) 3,4-di-υποκαθισταμενες cyclobutene-1,2-diones ως συνδετες του υποδοχεα των cxc-χημειοκινων
JO2654B1 (en) Multiple aryl caroxa amides are useful as lipid - lowering agents
NO20041493L (no) Kjemiske forbindelser.
DE60235900D1 (de) Osuppressivum
ATE270817T1 (de) Fungizide
BR0010690A (pt) Composições de poliuretano-uréia contendo silìcio
TW200600971A (en) Calixresorcinarene compounds, photoresist base materials, and compositions thereof
TR200201683T2 (tr) İkameli fenil-piperazin türevleri, bunların hazırlanması ve kullanımları
ATE354622T1 (de) Flüssigkristallines medium
SE0101038D0 (sv) Novel compounds
MXPA03009602A (es) Analogos de nociceptina.
WO2002034710A3 (fr) Intermediaires utiles pour la synthese de retinoides
BR0213481A (pt) Sondas
DE602004031115D1 (de) Pyrimidinverbindungen mit phosphonatgruppen als antivirale nucleotidanaloga
DE60232289D1 (de) Photopolymerisierbare Verbindungen
DE60216296D1 (de) Biologische vorstufen für die perkutane verabreichung
DE60117594D1 (de) 3-oxadiazol-5-yl-1-aminoalkyl-1h-indolderivate
DE60202669D1 (de) 6-phenylbenzonaphthyidine
MXPA02011234A (es) Nuevas bases de oxidacion 2,5-diaminopiridina utiles para el tinte de las fibras queratinicas.
DE60006063D1 (de) Bis-terpyridinplatinkomplexe
EP1570837A4 (de) Dendrit-verlängerungs-inhibitor zur melanozyt- und haut-präparation zur äusseren verwendung, umfassend denselben.
ATE319708T1 (de) Azol- oder triazol-derivate, verfahren zu deren herstellung und ihre verwendung als fungizide
BR0315508A (pt) Processo para preparação de compostos de pirazol
ATE283861T1 (de) Organische molybdänkomplexe als reibungsveränderer
SE0402734D0 (sv) Antimiicrobial compounds

Legal Events

Date Code Title Description
8364 No opposition during term of opposition